VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 125 filers reported holding VOYAGER THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.17 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $58 | -54.7% | 7,572 | -54.4% | 0.00% | – |
| Q1 2023 | $128 | -93.6% | 16,623 | +2196.0% | 0.00% | – |
| Q3 2021 | $2,000 | -83.3% | 724 | -72.6% | 0.00% | – |
| Q1 2021 | $12,000 | -20.0% | 2,642 | +80.3% | 0.00% | – |
| Q3 2020 | $15,000 | +7.1% | 1,465 | +32.0% | 0.00% | – |
| Q2 2020 | $14,000 | -26.3% | 1,110 | -47.0% | 0.00% | – |
| Q1 2020 | $19,000 | -87.1% | 2,095 | -80.2% | 0.00% | – |
| Q4 2019 | $147,000 | +32.4% | 10,598 | +63.1% | 0.00% | – |
| Q3 2019 | $111,000 | -82.9% | 6,499 | -72.8% | 0.00% | -100.0% |
| Q2 2019 | $650,000 | +112.4% | 23,897 | +49.2% | 0.00% | +100.0% |
| Q1 2019 | $306,000 | – | 16,016 | +16242.9% | 0.00% | – |
| Q4 2018 | $0 | -100.0% | 98 | -74.7% | 0.00% | – |
| Q3 2018 | $7,000 | +40.0% | 387 | +41.8% | 0.00% | – |
| Q2 2018 | $5,000 | -28.6% | 273 | -26.8% | 0.00% | – |
| Q1 2018 | $7,000 | -96.6% | 373 | -97.0% | 0.00% | -100.0% |
| Q4 2017 | $207,000 | +2487.5% | 12,516 | +2982.8% | 0.01% | – |
| Q3 2017 | $8,000 | – | 406 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 6,391,176 | $60,077,000 | 50.34% |
| ARMISTICE CAPITAL, LLC | 2,836,000 | $26,658,000 | 2.02% |
| Casdin Capital, LLC | 1,128,075 | $10,604,000 | 1.81% |
| BB BIOTECH AG | 2,865,841 | $26,939,000 | 0.86% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 1,284,697 | $12,076,000 | 0.81% |
| Aevitas Wealth Management, Inc. | 48,300 | $454,000 | 0.46% |
| GREAT POINT PARTNERS LLC | 365,132 | $3,432,000 | 0.43% |
| Patriot Financial Group Insurance Agency, LLC | 61,320 | $576,000 | 0.38% |
| HARBOURVEST PARTNERS LLC | 72,726 | $684,000 | 0.32% |
| Birchview Capital, LP | 33,000 | $310,000 | 0.29% |